• M344 Histone Deacetylase Inhibitor Workflows

  2026-09-01

  M344 connects HDAC inhibition with practical assays for chromatin remodeling, tumor-cell suppression, differentiation, migration, radiation response, and viral latency. This workflow-focused guide helps researchers select concentrations, pair orthogonal endpoints, and troubleshoot solubility or treatment-related toxicity.

• Tamoxifen as a Translational Control Lever

  2026-09-01

  Tamoxifen is more than a selective estrogen receptor modulator: it is a context-sensitive experimental control for cancer biology, inducible genetics, and mechanistic studies of autophagy. This thought-leadership article connects tamoxifen-enabled CreER workflows with new evidence linking PINK1 deficiency to mitochondrial iron accumulation and colon tumorigenesis, while outlining safeguards for translational interpretation.

• AP20187 for Reliable Cell Assays

  2026-08-31

  Learn how AP20187 (SKU B1274) supports controlled signaling in viability, proliferation, and cytotoxicity workflows through chemical-induced fusion protein dimerization. This scenario-based guide covers compatibility, stock preparation, data interpretation, and evidence-based product selection.

• Nuclear PI3P, Vps34, and DNA Mismatch Repair

  2026-08-31

  The reference study identifies nuclear phosphatidylinositol-3-phosphate (PI3P), produced by a Beclin-1/Vps34 complex, as a functional regulator of DNA mismatch repair (MMR). Its findings connect Vps34 biology to genome maintenance through MutS complex assembly, microsatellite stability, and DNA damage responses, extending investigation beyond canonical autophagy and vesicle trafficking.

• Ibrexafungerp Against Resistant Candida auris

  2026-08-30

  The reference study shows that ibrexafungerp retained in vitro activity against fluconazole-resistant Candida auris and improved outcomes in a neutropenic mouse model even when therapy was delayed. Its oral triterpenoid mechanism expands glucan-targeting strategies beyond injectable echinocandins and provides a useful framework for resistant Candida research.

• IR-1061: Designing Reliable OTN-NIR Assays

  2026-08-29

  IR-1061 is a near infrared fluorescent dye for OTN-NIR imaging, but assay performance depends on formulation, storage, and optical controls. This guide translates polymer-micelle evidence into practical decisions for reproducible biomedical and deep-tissue imaging workflows.

• Dietary Arachidonic Acid and Humoral Immunity

  2026-08-28

  A 2025 study reports that dietary arachidonic acid enhances rabies vaccine-induced neutralizing antibodies in mice and accelerates protective antibody development in human volunteers. The work identifies lymph-node enrichment and a prostaglandin I2–cAMP–PKA pathway linking dietary lipid metabolism to CD86 expression and activation-induced cytidine deaminase in B cells.

• a-MSH, amide: A Better Melanogenesis Control

  2026-08-28

  a-MSH, amide provides a defined melanocortin stimulus for separating receptor-driven melanin synthesis from downstream inhibition. This article explains how to use alpha-melanocyte-stimulating hormone amide as an assay anchor, interpret CREB/MITF findings, and connect pigmentation with inflammation research.

• Catalpol in Alzheimer’s Disease: Mechanisms and Evidence

  2026-08-27

  The 2022 reference review presents catalpol as a multitarget iridoid glycoside with antioxidant, anti-inflammatory, antiapoptotic, and mitochondrial-protective effects relevant to Alzheimer’s disease. Its main contribution is an integrated mechanistic framework, while its preclinical evidence also highlights the need for standardized models, dose comparisons, and clinical validation.

• Pyridostatin TFA: G-Quadruplex Research Guide

  2026-08-27

  Pyridostatin is a synthetic G-quadruplex stabilizer used to study telomere dysfunction and cancer cell growth. Pyridostatin TFA is the commonly used salt form, with vendor-reported activity in human cell models and defined handling parameters.

• (1S,3R)-RSL3: GPX4 Inhibitor Guide

  2026-08-26

  RSL3 is a direct glutathione peroxidase 4 inhibitor that triggers ferroptosis by weakening cellular protection against lipid peroxidation. This guide connects its GPX4 mechanism, RAS-linked preclinical activity, formulation limits, and evidence-based workflow controls.

• Doxorubicin HCl: A Translational Assay Framework

  2026-08-26

  Doxorubicin hydrochloride is more than a cytotoxic agent: it is a powerful tool for separating DNA damage, energy stress, tumor-cell apoptosis, and cardiac injury. This article presents an assay-centered framework grounded in recent ferroptosis and cardiotoxicity findings.

• Sisomicin Workflows for In Vitro Antibacterial Testing

  2026-08-25

  Sisomicin provides a practical benchmark for susceptibility testing across clinically relevant Gram-negative and Gram-positive organisms. This guide translates primary isolate data into reproducible assay setup, resistance-aware comparisons, and troubleshooting decisions for infection research.

• TMEM16F in Kupffer Cells Protects Against Listeria

  2026-08-25

  This 2024 Advanced Science study identifies Kupffer cell-expressed TMEM16F, rather than T- or B-cell TMEM16F, as a key determinant of host protection against Listeria monocytogenes. By combining cell type-specific mouse genetics with plasma-membrane injury, inflammation, and liver-metabolism analyses, the work connects lipid scrambling and membrane repair to control of bacterial tissue damage.

• Cyclopamine: Hedgehog Signaling Inhibitor Workflows

  2026-08-24

  Cyclopamine enables controlled Smoothened perturbation across cancer, developmental, and olfactory biology experiments. This practical guide connects dose-response screening with apoptosis, pathway validation, electrophysiology, and behavior while highlighting formulation, exposure, and interpretation safeguards.

8055 records 1/537 page Next 12345 下5页 Last page